This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Esophagogastric junction outflow obstruction is a condition in which there is an obstruction in the outflow of food and liquids from the esophagus to the stomach. This obstruction can lead to a variety of symptoms, including chest pain, difficulty swallowing, and regurgitation. In some cases, the obstruction can be caused by a tumor or other physical blockage of the esophagus. The first step in diagnosing esophagogastric junction outflow obstruction is typically an upper endoscopy. During this procedure, a thin tube with a tiny camera is inserted through the mouth and into the esophagus to examine the inside of the esophagus and stomach. If any blockages are found, they can then be removed with endoscopic tools. If a tumor is found, it may need to be surgically removed. Treatment for esophagogastric junction outflow obstruction varies depending on the cause of the obstruction. If it is caused by a physical obstruction such as a tumor, then surgery may be needed to remove it. If it is caused by an infection or inflammation, antibiotics or anti-inflammatory medications may be prescribed. In some cases, lifestyle changes such as reducing stress and eating smaller meals more frequently may help reduce symptoms. Esophagogastric junction outflow obstruction can be a serious condition and can lead to complications if left untreated. It is important to see a doctor if you experience any of the symptoms associated with this condition so that an accurate diagnosis can be made and appropriate treatment can be started as soon as possible.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States